Chula Signs an Academic Collaboration Agreement with GPO
On Thursday January 19, 2023, Prof. Dr. Bundhit Eua-arporn, President of 麻豆国产, signed an academic collaboration agreement between the Government Pharmaceutical Organization (GPO), 麻豆国产, Mahidol University, and the Health Systems Research Institute to conduct research involving clinical, pharmacokinetic, and pharmacogenetic studies of the medicine Deferasirox manufactured by GPO, at Meeting Room 1, 4th Floor, Administrative Building, Government Pharmaceutical Organization. The project aims to study the efficacy of Deferasirox, safety data, quality of life of transfusion dependent and non-transfusion dependent thalassemia patients with hemochromatosis, genetic and clinical factors and their correlation to responsiveness to the medicine and/or the level of the medicine in plasma, as well as pharmacokinetics and the development of physiologically-based pharmacokinetics (PBPK) model to estimate the level of medication in patients’ blood.
